☆ 4.6 Editorial Material

Vaccinations in patients with multiple sclerosis: review and recommendations

MEDICAL JOURNAL OF AUSTRALIA (2021)

期刊

MEDICAL JOURNAL OF AUSTRALIA

卷 214, 期 8, 页码 350-+

出版社

WILEY

DOI: 10.5694/mja2.51012

关键词

-

类别

Medicine, General & Internal

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Biotechnology & Applied Microbiology

Vaccinations in patients with multiple sclerosis: a real-world, single-center experience

Elvira Sbragia, Dario Olobardi, Giovanni Novi, Caterina Lapucci, Maria Cellerino, Giacomo Boffa, Alice Laroni, Malgorzata Mikulska, Laura Sticchi, Matilde Inglese

Summary: This study describes the vaccination coverage rates, timing proposals, and safety of vaccinating patients with multiple sclerosis (MS) undergoing disease-modifying drugs (DMDs) before the start of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination campaign. The study confirms the feasibility and safety of a vaccination protocol in MS patients with a median duration of 27 days.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

添加到收藏夹

Article Immunology

Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients

Helly Hammer, Robert Hoepner, Christoph Friedli, Stephen L. Leib, Franziska Suter-Riniker, Lara Diem, Nicole Kamber, Andrew Chan, Anke Salmen, Christian P. Kamm

Summary: This study compared the antibody response in multiple sclerosis patients after vaccination with two mRNA vaccines. The results showed that the protective antibody titers were low and decreased over time.

VACCINES (2022)

添加到收藏夹

Article Clinical Neurology

SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod

Lil Meyer-Arndt, Julian Braun, Florent Fauchere, Kanika Vanshylla, Lucie Loyal, Larissa Henze, Beate Kruse, Manuela Dingeldey, Karsten Juerchott, Maike Mangold, Ardit Maraj, Andre Braginets, Chotima Boettcher, Andreas Nitsche, Kathrin de la Rosa, Christoph Ratswohl, Birgit Sawitzki, Pavlo Holenya, Ulf Reimer, Leif E. Sander, Florian Klein, Friedemann Paul, Judith Bellmann-Strobl, Andreas Thiel, Claudia Giesecke-Thiel

Summary: This study investigated the impact of disease-modifying therapies (DMTs) on the immunogenicity of SARS-CoV-2 mRNA vaccines in patients with autoimmune diseases. The results showed that patients treated with fingolimod had no immune response even after booster vaccinations, putting them at risk for severe SARS-CoV-2 infections.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

添加到收藏夹

Review Clinical Neurology

Vaccinations in multiple sclerosis patients receiving disease-modifying drugs

Susana Otero-Romero, Alberto Ascherio, Christine Lebrun-Frenay

Summary: New evidence supports the lack of causal link between MS and vaccination, with consensus statements emphasizing the importance of starting vaccination early. Timing adjustments for vaccine administration are necessary to ensure safety and optimize vaccine responses in light of potential interference from DMDs. Patients on B-cell depleting therapies like Ocrelizumab are at risk of reduced immunogenicity to vaccines, highlighting the implications for upcoming SARS-CoV-2 vaccination.

CURRENT OPINION IN NEUROLOGY (2021)

添加到收藏夹

Review Immunology

Multiple Sclerosis, Disease-Modifying Therapies and COVID-19: A Systematic Review on Immune Response and Vaccination Recommendations

Veronica Cabreira, Pedro Abreu, Ricardo Soares-dos-Reis, Joana Guimaraes, Maria Jose Sa

Summary: Most MS patients receiving DMTs do not have a higher risk of severe COVID-19, but factors like age, comorbidities, and disability can significantly impact outcomes. While most DMTs have minimal influence on COVID-19, therapies causing severe lymphopenia and hypogammaglobulinemia, like anti-CD20 therapies, may lead to increased hospitalization, worse outcomes, and higher reinfection risk.

VACCINES (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?

Shani Witman Tsur, Eli Adrian Zaher, Meydan Tsur, Karolina Kania, Alicja Kalinowska-Lyszczarz

Summary: Vaccines stimulate the immune system to protect against specific pathogens, and there is currently no evidence to suggest that various vaccines increase the risk for multiple sclerosis patients. Further research is needed to explore the potential protective implications of certain vaccines in MS patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Review Clinical Neurology

Vaccinations in patients with multiple sclerosis: A Delphi consensus statement

Agostino Riva, Valeria Barcella, Simone Benatti, Marco Capobianco, Ruggero Capra, Paola Cinque, Giancarlo Comi, Maria Michela Fasolo, Fabio Franzetti, Massimo Galli, Simonetta Gerevini, Luca Meroni, Massimo Origoni, Luca Prosperini, Massimo Puoti, Cristina Scarpazza, Carla Tortorella, Mauro Zaffaroni, Lucia Moiola

Summary: Recommendations for vaccinations in patients with multiple sclerosis include considering risks and benefits carefully, and there is an urgent need for more research to guide evidence-based decision making.

MULTIPLE SCLEROSIS JOURNAL (2021)

添加到收藏夹

Review Nutrition & Dietetics

Clinical and Imaging Outcomes after Vitamin D Supplementation in Patients with Multiple Sclerosis: A Systematic Review

Julie Langlois, Damien Denimal

Summary: This systematic review examined the effects of vitamin D supplementation on clinical and imaging outcomes in patients with multiple sclerosis (MS). The results showed no significant impact of vitamin D supplementation on relapse events, disability progression, and magnetic resonance imaging (MRI) lesions. However, recent studies found a significant reduction in new MRI lesions in the central nervous system of MS patients during supplementation with vitamin D3.

NUTRIENTS (2023)

添加到收藏夹

Article Environmental Sciences

Awareness of COVID-19 Symptoms, Risk Factors, and Vaccinations in Patients with Multiple Sclerosis

Ewa Krzystanek, Agata Jurczak, Kinga Kocur, Jakub Jurkiewicz, Aleksandra Kaczmarczyk

Summary: The study reveals that Polish patients with MS have a good understanding of COVID-19 disease, are compliant with public regulations, but have insufficient willingness to get vaccinated, with only two-thirds expressing a desire for vaccination. Some patients are fearful of COVID-19, but only a minority are willing to receive a vaccine.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

添加到收藏夹

Review Geriatrics & Gerontology

Systematic Review of Studies on Telomere Length in Patients with Multiple Sclerosis

Jan Buehring, Michael Hecker, Brit Fitzner, Uwe Klaus Zettl

Summary: A review of the literature found that shorter telomeres in patients with MS were associated with greater disability, lower brain volume, increased relapse rate, and more rapid conversion from relapsing to progressive MS. Despite limited studies, there is substantial evidence supporting the association of telomere length with MS.

AGING AND DISEASE (2021)

添加到收藏夹

Article Clinical Neurology

Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis

Maria Cellerino, Giacomo Boffa, Caterina Lapucci, Francesco Tazza, Elvira Sbragia, Elisabetta Mancuso, Nicolo Bruschi, Simona Minguzzi, Federico Ivaldi, Ilaria Poire, Alice Laroni, Gianluigi Mancardi, Elisabetta Capello, Antonio Uccelli, Giovanni Novi, Matilde Inglese

Summary: The study found that ocrelizumab is an effective and safe treatment for patients with RRMS and PMS, with better outcomes observed in treatment-naive patients and those with lower baseline disability levels. Depletion of CD8 + cells may be a key factor in the early therapeutic effects of ocrelizumab.

NEUROTHERAPEUTICS (2021)

添加到收藏夹

Review Clinical Neurology

COVID-19 Among Patients With Multiple Sclerosis A Systematic Review

Mahdi Barzegar, Omid Mirmosayyeb, Mahsa Gajarzadeh, Alireza Afshari-Safavi, Nasim Nehzat, Saeed Vaheb, Vahid Shaygannejad, Amir-Hadi Maghzi

Summary: During the COVID-19 pandemic, patients with MS had a lower infection rate and did not significantly increase mortality rate after contracting the disease. The most common symptoms were fever, cough, and fatigue. Specific treatment methods may affect the hospitalization and mortality rates of patients.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)

添加到收藏夹

Review Immunology

Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review

Tiziana Ciarambino, Pietro Crispino, Pietro Buono, Vincenzo Giordano, Ugo Trama, Vincenzo Iodice, Laura Leoncini, Mauro Giordano

Summary: With the increasing aging population, vaccination of the elderly has become crucial in order to reduce mortality and healthcare costs. However, the efficacy and safety of vaccines in the elderly are different due to the decline in immune system efficiency. Strategies such as supplementary doses with adjuvant vaccines and increasing the antigen dosage can improve the effectiveness of vaccination. Vaccination in old age can also indirectly contribute to combating antibiotic resistance.

VACCINES (2023)

添加到收藏夹

Review Clinical Neurology

Fampridine for gait imbalance in patients with multiple sclerosis (MS): a systematic review and meta-analysis

Sahar Ghorbanpour, Sarvenaz Rahimibarghani, Setareh Rohani, Mohsen Rastkar, Mahsa Ghajarzadeh

Summary: This systematic review and meta-analysis found that fampridine improves gait imbalance in patients with multiple sclerosis (MS).

NEUROLOGICAL SCIENCES (2023)

添加到收藏夹

Review Immunology

Incidence and Risk of Infection Associated With Fingolimod in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis of 8,448 Patients From 12 Randomized Controlled Trials

Zhao Zhao, Chun-Lai Ma, Zhi-Chun Gu, Yue Dong, Yang Lv, Ming-Kang Zhong

Summary: Fingolimod treatment in patients with multiple sclerosis is associated with a significant increase in infection risk, with a 16% higher risk compared to placebo and other active treatments. The risk is especially elevated for lower respiratory infections and herpes virus infections, and does not appear to be dose-dependent.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Ethnic Studies

Understanding the types of racism and its effect on mental health among Muslim women in Victoria

Tahira Yeasmeen, Margaret Kelaher, Julia M. L. Brotherton

Summary: This study investigates the different types of racism experienced by Muslim and non-Muslim women living in Victoria, Australia, and the adverse mental health outcome they face after experiencing racism.

ETHNICITY & HEALTH (2023)

添加到收藏夹

Article Clinical Neurology

Prediction of relapse activity when switching to cladribine for multiple sclerosis

Michael Zhong, Anneke van der Walt, Mastura Monif, Suzanne Hodgkinson, Sara Eichau, Tomas Kalincik, Jeannette Lechner-Scott, Katherine Buzzard, Olga Skibina, Vincent Van Pesch, Ernest Butler, Julie Prevost, Marc Girard, Jiwon Oh, Helmut Butzkueven, Vilija Jokubaitis

Summary: Relapse during or prior to the treatment gap, and younger age, were found to be prognostic factors in the year after switching to cladribine. Switching from NTZ was also independently associated with a higher risk of relapse.

MULTIPLE SCLEROSIS JOURNAL (2023)

添加到收藏夹

Review Immunology

Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs

Lauri E. Markowitz, Melanie Drolet, Rayleen M. Lewis, Philippe Lemieux-Mellouki, Norma Perez, Mark Jit, Julia M. Brotherton, Gina Ogilvie, Aimee R. Kreimer, Marc Brisson

Summary: This study provides a systematic literature review on the effectiveness of HPV vaccines. It highlights the biases in observational studies and the need for further research to obtain valid effectiveness estimates.

VACCINE (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

The spread of coronavirus disease 2019 (COVID-19) via staff work and household networks in residential aged-care services in Victoria, Australia, May-October 2020

Sheena G. Sullivan, Giovanni Radhitio P. Sadewo, Julia M. Brotherton, Claire Kaufman, Jessie J. Goldsmith, Sarah Whiting, Logan Wu, Jose T. Canevari, Dean Lusher

Summary: Restricting visitor access and encouraging staff to work at a single site can help prevent the spread of COVID-19 in residential aged-care services. This study found that multi-site work and household contacts were the main factors contributing to the spread of the virus in aged-care facilities. Therefore, limiting staff mobility and reducing transmission through household networks are essential measures to prevent outbreaks.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

添加到收藏夹

Article Oncology

Public health opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule

Aimee R. Kreimer, Tania Cernuschi, Helen Rees, Julia M. L. Brotherton, Carolina Porras, John Schiller

Summary: Many countries burdened by cervical cancer have not provided HPV vaccines to most eligible girls, resulting in limited access to screening and treatment. However, the increased vaccine supply and single-dose recommendation provide an opportunity to expand vaccination and prevent millions of projected cervical cancer cases.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

添加到收藏夹

Article Virology

Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening

Louiza S. Veientzis, David Hawkes, Michael Caruanaa, Julia ML. Brotherton, Megan A. Smith, Lara Roeske, Khurram A. Karim, Suzanne M. Garland, C. David Wrede, Jeffery Tan, Cosette Wheeler, Philip E. Castle, Marion Saville, Karen Canfell

Summary: Australia's cervical screening program transitioned to HPV testing in December 2017 and we investigated the impact of the HPV vaccination program on HPV16/18 prevalence. The results showed a significant reduction in HPV16/18 prevalence after vaccination compared to pre-vaccination levels.

TUMOUR VIRUS RESEARCH (2023)

添加到收藏夹

Editorial Material Medicine, General & Internal

Japanese encephalitis virus: changing the clinical landscape of encephalitis in Australia

Sarah Allen, Celia M. Cooper, Ajay Taranath, Allen C. Cheng, Philip N. Britton

MEDICAL JOURNAL OF AUSTRALIA (2023)

添加到收藏夹

Article Immunology

Informing the design of a whole of life immunisation register for Australia

Elizabeth B. Kpozehouen, Robert Menzies, Holly Seale, Julia Brotherton, C. Raina Macintyre

Summary: In 2016, Australia launched the Australian Immunisation Register (AIR), a national immunisation system covering all age groups. Recommendations from a national workshop have been integrated into the current version of AIR, improving the accuracy and validity of data. However, access to AIR data for research purposes remains limited.

VACCINE (2023)

添加到收藏夹

Article Oncology

Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis

Maria Pia Campagna, Alexandre Xavier, Jim Stankovich, Vicki E. Maltby, Mark Slee, Wei Z. Yeh, Trevor Kilpatrick, Rodney J. Scott, Helmut Butzkueven, Jeannette Lechner-Scott, Rodney A. Lea, Vilija G. Jokubaitis

Summary: This study aimed to identify DNA methylation patterns associated with parity in women with relapse-onset multiple sclerosis (wwMS). The results showed differential methylation in whole blood and immune cell types, particularly in genes related to neural plasticity. Additionally, it was found that parous women exhibited slower biological aging compared to nulligravida women.

CLINICAL EPIGENETICS (2023)

添加到收藏夹

Editorial Material Biology

POINT OF VIEW COVID-19 as a catalyst for reimagining cervical cancer prevention

Rebecca Luckett, Sarah Feldman, Yin Ling Woo, Anna-Barbara Moscicki, Anna R. Giuliano, Silvia de Sanjose, Andreas M. Kaufmann, Shuk On Annie Leung, Francisco Garcia, Karen Chan, Neerja Bhatla, Margaret Stanley, Julia Brotherton, Joel Palefsky, Suzanne Garland

Summary: Cervical cancer has claimed the lives of millions of women in the past decade. Despite challenges posed by the COVID-19 pandemic, lessons learned in vaccination, self-testing, and global coordination may aid in achieving the goals set by the Cervical Cancer Elimination Strategy. However, it is crucial to include the perspectives of all countries involved in order to effectively eliminate cervical cancer.

ELIFE (2023)

添加到收藏夹

Article Infectious Diseases

Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 2016-2019

Joanne Jackson, Nicole Sonneveld, Harunor Rashid, Larissa Karpish, Seaneen Wallace, Lisa Whop, Cyra Patel, Julia Brotherton, Han Wang, Alexandra Hendry, Brynley Hull, Katrina Clark, Stephen Lambert, Aditi Dey, Frank Beard

Summary: This report is the fifth comprehensive report by the National Centre for Immunisation Research and Surveillance (NCIRS) on vaccine preventable diseases (VPDs) and vaccination coverage in Aboriginal and Torres Strait Islander people from 2016 to 2019. It analyzes and assesses data on notifications, hospital admissions, deaths, and vaccination coverage to support service delivery, policy development, and further research. The report highlights achievements in improving the health of Aboriginal and Torres Strait Islander people through immunization programs and suggests future directions.

COMMUNICABLE DISEASES INTELLIGENCE (2023)

添加到收藏夹

Article Public, Environmental & Occupational Health

Complex intervention to promote human papillomavirus (HPV) vaccine uptake in school settings: A cluster-randomized trial

Cristyn Davies, Helen S. Marshall, Julia M. L. Brotherton, Kirsten McCaffery, Melissa Kang, Kristine Macartney, Suzanne M. Garland, John Kaldor, Gregory Zimet, S. Rachel Skinner

Summary: This study aimed to evaluate a complex intervention to increase HPV vaccination uptake in schools. The intervention included education, shared decision-making, and logistical strategies. The study found no difference in vaccine uptake between the intervention and control groups, with both groups having similar vaccination rates.

PREVENTIVE MEDICINE (2023)

添加到收藏夹

Article Immunology

Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection

Bette Liu, Sandrine Stepien, Jiahui Qian, Heather Gidding, Katrina Nicolopoulos, Janaki Amin, Allen Cheng, Kristine Macartney

Summary: This study compared the effectiveness of different COVID-19 vaccines. The results showed that the BNT162b2 mRNA vaccine had higher effectiveness in preventing primary infections compared to mRNA-1273, ChAdOx-1 nCov-19, and NVX-CoV2373. For booster doses, the BNT162b2 mRNA vaccine also showed good effectiveness.

VACCINE (2023)

添加到收藏夹

Article Primary Health Care

'I'm a bit of a champion for it actually': qualitative insights into practitioner-supported self-collection cervical screening among early adopting Victorian practitioners in Australia

Claire Zammit, Nicola Creagh, Claire Nightingale, Tracey McDermott, Marion Saville, Julia Brotherton, Margaret Kelaher

Summary: Self-collection for cervical screening has been available in Australia since 2017 and has been well-received by practitioners. However, there are varying levels of knowledge and awareness about self-collection among primary care workers. Practitioners play a crucial role in promoting self-collection and addressing practical barriers, but there are concerns about follow-up for HPV-positive patients and obtaining accurate screening histories.

PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT (2023)

添加到收藏夹

Article Oncology

Understanding the Challenges of HPV-Based Cervical Screening: Development and Validation of HPV Testing and Self-Sampling Attitudes and Beliefs Scales

Ovidiu Tatar, Ben Haward, Patricia Zhu, Gabrielle Griffin-Mathieu, Samara Perez, Emily McBride, Aisha K. Lofters, Laurie W. Smith, Marie-Helene Mayrand, Ellen M. Daley, Julia M. L. Brotherton, Gregory D. Zimet, Zeev Rosberger

Summary: The study aimed to develop and validate two scales measuring attitudes and beliefs towards HPV testing and self-sampling. Exploratory Factor Analysis (EFA) and parallel analysis were used to determine the optimal number of factors, and Item Response Theory (IRT) was applied to select items. After data cleaning, 1027 responses were analyzed. Confirmatory Factor Analysis (CFA) showed a good model fit for both final scales. These scales will be a valuable resource to examine attitudes and beliefs in anticipation of, and to evaluate, HPV test-based cervical screening.

CURRENT ONCOLOGY (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.